Form 4: Milton Boniuk's Ownership in Nanoviricides Reduced Below Reporting Threshold

A recent SEC filing indicates that Milton Boniuk's ownership percentage in Nanoviricides, Inc. has fallen below the reporting threshold due to the company issuing new securities.

Summary

• Milton Boniuk, previously a 10% owner of Nanoviricides, Inc., has had his ownership stake reduced below the reporting threshold.
• This change is due to the company issuing new securities, which diluted Boniuk's percentage of ownership.
• The filing details transactions involving common stock and Series A Convertible Preferred Stock.
• Boniuk's holdings include both direct and indirect ownership through Boniuk Interests Ltd and a Milton Boniuk IRA.
• The Series A Convertible Preferred Stock can be converted into common stock upon a change of control of the Issuer at a rate of 3.5 shares of common stock for each share of preferred stock.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of ownership changes. While dilution can be seen as negative, it's a normal part of corporate finance. The sentiment is therefore neutral.

Negatives

• Milton Boniuk's ownership percentage has been reduced, which could be seen as a negative signal by some investors.

Risks

• The dilution of ownership could potentially impact the influence of previous major shareholders.
• The issuance of new securities may indicate a need for capital, which could be a risk if not managed effectively.

Industry Context

This filing is a standard SEC disclosure related to changes in beneficial ownership. It is common for companies to issue new securities, which can lead to dilution of existing shareholders' ownership percentages. This is a normal part of corporate finance and capital raising activities.

Comparison to Industry Standards

• SEC Form 4 filings are a standard requirement for reporting changes in beneficial ownership for publicly traded companies in the United States.
• The reporting of ownership changes due to share dilution is a common occurrence in the biotechnology sector, where companies often raise capital through equity offerings.
• The conversion ratio of 3.5 common shares for each preferred share is within the typical range for convertible preferred stock in similar companies.

Stakeholder Impact

• Existing shareholders may experience a dilution of their ownership percentage.
• The company may have increased its capital base, which could be beneficial for future operations.

Key Dates

Keywords

Nanoviricides, NNVC, Milton Boniuk, Ownership, SEC Form 4, Securities, Convertible Preferred Stock, Share Dilution